Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Sunshine Biopharma, Inc. 

6100 Royalmount Avenue

Montreal  Quebec  H4P 2R2  Canada
Phone: 514-496-5197 Fax: 450-689-639



 Company News
Sunshine Biopharma, Inc. Signs Agreement With Lonza Biologics Inc. (LONN.VX) To Manufacture Its Lead Anti-Cancer Compound, Adva-27a 11/20/2014 8:42:07 AM
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/17/2014 10:53:25 AM
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/14/2014 8:41:48 AM
Sunshine Biopharma, Inc.'s Wholly Owned Canadian Subsidiary Completes The SOP's Required By Health Canada To Secure Drug Establishment License 10/3/2014 11:10:53 AM
Sunshine Biopharma, Inc. Negotiating With CRO's To Initiate Master Drug File For Adva-27a Anticancer Compound 9/4/2014 1:08:34 PM
Sunshine Biopharma, Inc. Launches Sunshine Biopharma Canada Inc., A Wholly Owned Canadian Subsidiary In Anticipation Of Signing Manufacturing And Commercialization Contracts In Canada 7/29/2014 11:40:17 AM
Sunshine Biopharma, Inc.'s Adva-27a Featured In 2014 Worldwide Uterine Cancer Report For Its Effectiveness Against Multidrug Resistant Uterine Cancer Cells 6/10/2014 10:22:28 AM
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In Canada 5/12/2014 10:17:01 AM
Sunshine Biopharma, Inc. Secures Funding For Its Adva-27a Anticancer Compound From Dutchess Opportunity Fund II 4/29/2014 11:10:19 AM
Sunshine Biopharma, Inc. Increases The Effectiveness Of Adva-27a Lead Compound 9.5-Fold Against Breast And Pancreatic Cancer In Vitro 4/8/2014 10:31:00 AM